Data Foundry

Drug recalls 2023

Dofetilide Capsules 250 mcg — Class II drug recall D-0384-2023

Terminated recall by Accord Healthcare, Inc., reported 2023-03-08, distributed in PR. CGMP Deviations: recalling drug products following an FDA inspection.

Recall numberD-0384-2023
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAccord Healthcare, Inc., Durham, NC, United States
Recall initiated2023-02-07
Classified2023-03-02
Reported by FDA2023-03-08
Terminated2024-04-22
DistributedPR
Countries outside the USCA
Quantity113,571 bottles
Reason classescgmp
UPC / GTIN / UDI-DI00316729491129
NDC16729-0490, 16729-0490-12, 16729-0490-59, 16729-0491, 16729-0491-12, 16729-0491-59, 16729-0492, 16729-0492-12, 16729-0492-59
Lot numbersP2101481, P2101958, P2101985, P2102019, P2102580, P2102597, P2104708, P2104712, P2107154, P2107187, P2107874, P2200772, P2200796, P2200817, P2200830, P2201196, P2201198, P2202610, P2203466
Expiration dates2023-02-28, 2023-03-31, 2023-04-30, 2023-06-30, 2023-10-31, 2023-11-30, 2023-12-31, 2024-01-31, 2024-12-31, 2025-04-30, 2025-05-31

Product

Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA NDC 16729-491-12 UPC 3 16729 49112 9

Reason for recall

CGMP Deviations: recalling drug products following an FDA inspection.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0384-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.